La maladie de Parkinson au Canada (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « E. Mohr »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
E. Moberg < E. Mohr < E. Monros  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
003859 (2000) E. Mohr [Canada] ; T. Mendis ; K. Hildebrand ; P P De DeynRisperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: an open pilot trial.
004124 (1997) E. Mohr [Canada] ; J J Claus [Pays-Bas] ; P. Brouwers [États-Unis]Basal ganglia disease and visuospatial cognition: Are there disease-specific impairments?
004388 (1996) L. Mcfadden [Canada] ; E. Mohr ; M. Sampson ; T. Mendis ; J D GrimesA profile analysis of demented and nondemented Parkinson's disease patients.
004563 (1996) J. J. Claus [Pays-Bas] ; E. Mohr [Canada]Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases
004626 (1995) E. Mohr [Canada] ; T. Mendis ; J D GrimesLate cognitive changes in Parkinson's disease with an emphasis on dementia.
004816 (1995) E. Mohr [Canada] ; T. Mendis ; J. D. GrimesLate cognitive changes in Parkinson's disease with an emphasis on dementia
004828 (1995) E. Mohr [Canada] ; P. Brouwers ; J. J. Claus ; S. E. Purdon [Canada] ; M. Gagnon [Canada] ; T. N. ChaseDifferential classification of dementia
004859 (1994) E. Mohr ; T. Mendis ; I N Rusk ; J D GrimesNeurotransmitter replacement therapy in Alzheimer's disease.
004A54 (1994) T. Mendis [Canada] ; E. Mohr [Canada] ; A. George ; I. N. Rusk [Canada] ; P. Gray ; J. D. GrimesSymptomatic relief from treatment-induced psychosis in Parkinson's disease: an open-label pilot study with remoxipride
004C95 (1992) E. Mohr [Canada] ; U M Mann ; R S Miletich ; M. Sampson ; T E Goldberg ; J D Grimes ; T N ChaseNeuropsychological and glucose metabolic profiles in asymmetric Parkinson's disease.
004D15 (1992) P. Vezina [Canada] ; E. Mohr ; D. GrimesDeprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects.
004E92 (1992) E. Mohr [Canada] ; U. M. Mann ; R. S. Miletich ; M. Sampson ; T. E. Godberg ; J. D. Grimes ; T. N. ChaseNeuropsychological and glucose metabolic profiles in asymmetric Parkinson's disease
004F06 (1992) P. Vezina [Canada] ; E. Mohr ; D. GrimesDeprenyl in Parkinson's disease : mechanisms, neuroprotective effect, indications and adverse effects

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "E. Mohr" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "E. Mohr" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    E. Mohr
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022